• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The use of streptokinase-streptodornase in the treatment of postneumonic empyema.

作者信息

TILLETT W S, SHERRY S, READ C T

出版信息

J Thorac Surg. 1951 Mar;21(3):275-97.

PMID:14814722
Abstract
摘要

相似文献

1
The use of streptokinase-streptodornase in the treatment of postneumonic empyema.链激酶-链道酶在肺炎后脓胸治疗中的应用。
J Thorac Surg. 1951 Mar;21(3):275-97.
2
[Treatment of pleural empyema with streptokinase and streptodornase].[用链激酶和链道酶治疗胸膜积脓]
Pediatr Pol. 1955 Dec;30(12):1145-52.
3
[Streptokinase-streptodornase. III. Its use in empyema].[链激酶-链道酶。III. 其在脓胸治疗中的应用]
Med Panam. 1956 Sep;7(3):191-4.
4
The use of streptokinase-streptodornase in the treatment of chronic empyema; with an interpretive discussion of enzymatic actions in the field of intrathoracic diseases.链激酶-链道酶在慢性脓胸治疗中的应用；对胸腔疾病领域酶作用的解释性讨论。
J Thorac Surg. 1951 Apr;21(4):325-41.
5
[Intrapleural use of streptokinase and streptodornase in postoperative pleural empyema].链激酶和链道酶在术后胸膜脓胸中的胸膜腔内应用
Bruns Beitr Klin Chir. 1956 Oct;193(2):167-86.
6
Streptokinase-streptodornase therapy of sterile postpneumonic empyema of long standing.链激酶-链道酶疗法治疗长期存在的无菌性肺炎后脓胸。
Calif Med. 1953 Nov;79(5):402-4.
7
The intrathoracic use of streptokinase-streptodornase.链激酶-链道酶的胸腔内应用。
Am Surg. 1953 Feb;19(2):128-47.
8
[Streptokinase and its clinical use, especially in pleural empyema].[链激酶及其临床应用，特别是在胸膜脓胸中的应用]
Ugeskr Laeger. 1951 Nov 22;113(47):1590-3.
9
[Decortication of the lung and resection of the cavity in the treatment of chronic empyema; review of cases treated by other methods and use of streptodornase and streptokinase in coagulated hemothorax].[肺剥脱术及空洞切除术治疗慢性脓胸；其他治疗方法治疗病例回顾及链道酶和链激酶在凝固性血胸治疗中的应用]
Dia Med. 1953 May 11;25(25):606-14.
10
[The clinical effects of streptodornase and streptokinase in purulent exudation and their interpretation as the result of simple irritation].[链道酶和链激酶在脓性渗出物中的临床作用及其作为单纯刺激结果的解释]
Klin Wochenschr. 1953 May 1;31(17-18):423-6. doi: 10.1007/BF01472497.

引用本文的文献

1
Intrapleural Fibrinolytic Interventions for Retained Hemothoraces in Rabbits.兔血胸遗留中胸腔内纤维蛋白溶解介入治疗。
Int J Mol Sci. 2024 Aug 12;25(16):8778. doi: 10.3390/ijms25168778.
2
Tissue plasminogen activator with prolonged dwell time effectively evacuates pleural effusions.具有延长驻留时间的组织型纤溶酶原激活物能有效地排出胸腔积液。
BMC Pulm Med. 2022 Dec 5;22(1):464. doi: 10.1186/s12890-022-02261-y.
3
A Comparative Study of the Safety and Efficacy of Intrapleural Fibrinolysis With Streptokinase and Urokinase in the Management of Loculated Pleural Effusions.
链激酶与尿激酶胸膜内纤维蛋白溶解术治疗局限性胸腔积液的安全性和有效性比较研究
Cureus. 2022 Jun 24;14(6):e26271. doi: 10.7759/cureus.26271. eCollection 2022 Jun.
4
Extended Dwell Time Improves Results of Fibrinolytic Therapy for Complex Pleural Effusions.延长留置时间可改善复杂胸腔积液的纤溶治疗效果。
Cureus. 2020 Aug 11;12(8):e9664. doi: 10.7759/cureus.9664.
5
Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.胸膜内纤维蛋白溶解疗法与安慰剂或不同的纤维蛋白溶解剂在治疗成人肺炎旁胸腔积液和脓胸中的比较。
Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD002312. doi: 10.1002/14651858.CD002312.pub4.
6
Phase 1 trial of intrapleural LTI-01; single chain urokinase in complicated parapneumonic effusions or empyema.LTI-01（单链尿激酶）胸腔内给药治疗复杂性类肺炎性胸腔积液或脓胸的 1 期临床试验。
JCI Insight. 2019 Apr 18;5(10):127470. doi: 10.1172/jci.insight.127470.
7
Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper.了解中高危肺栓塞患者溶栓治疗后的出血风险：一篇假说论文。
Open Heart. 2018 Feb 26;5(1):e000735. doi: 10.1136/openhrt-2017-000735. eCollection 2018.
8
Fibrin turnover and pleural organization: bench to bedside.纤维蛋白转换与胸膜组织：从基础到临床。
Am J Physiol Lung Cell Mol Physiol. 2018 May 1;314(5):L757-L768. doi: 10.1152/ajplung.00501.2017. Epub 2018 Jan 18.
9
Precision-guided, Personalized Intrapleural Fibrinolytic Therapy for Empyema and Complicated Parapneumonic Pleural Effusions: The Case for the Fibrinolytic Potential.精准引导、个性化的胸膜内纤维蛋白溶解疗法治疗脓胸和复杂性肺炎旁胸腔积液：纤维蛋白溶解潜力的实例
Clin Pulm Med. 2017 Jul;24(4):163-169. doi: 10.1097/CPM.0000000000000216.
10
The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study.系统性红斑狼疮患者浆膜炎的患病率及危险因素：一项横断面研究。
Rheumatol Int. 2017 Feb;37(2):305-311. doi: 10.1007/s00296-016-3630-0. Epub 2016 Dec 20.